CTRI/2012/03/002483进行中（未招募）3 期
To Evaluate the effect of Metformin versus Placebo as an Add-on Therapy in patients with recurrent epithelial ovarian cancer receiving chemotherapy: A double blind randomized controlled clinical trial.
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of recurrent epithelial ovarian cancer
- •Age more than 18 years and up to 70 years
排除标准
- •?Patient with diabetes mellitus
- •?Patients who have received metformin or another mTOR inhibitor in the last 2 years
- •?Patients with deranged liver or renal profile
- •?Patients with known hypersensitivity to metformin
研究者
相似试验
进行中（未招募）
不适用
A Trial of Metformin in Early Breast CancerEarly Breast CancerMedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005230-18-GBCIC Clinical Trials Group3,582
进行中（未招募）
1 期
A randomised placebo-controlled trial of metformin on progression of carotid atherosclerosis in non-diabetic patients with cardiovascular disease treated with conventional risk reducing agents - CAMERA: Carotid Atherosclerosis: MEtformin for insulin ResistAnce studyEUCTR2008-002169-30-GBGreater Glasgow Health Board, Research and Development Department220
进行中（未招募）
1 期
Prevention of chronic diseases through diet and metformiEUCTR2012-005427-32-ITFondazione IRCCS Istituto Nazionale dei Tumori2,000
招募中
3 期
The influence of modafinil on the post-exercise exacerbation of symptoms in patients with chronic fatigue syndromechronic fatigue syndromeOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12616000487415niversity of New South Wales20
进行中（未招募）
1 期
A randomised controlled clinical trial of metformin versus orlistat for the management of obses anovulatory women - n/aEUCTR2005-002096-32-GBSheffield Teaching Hospitals NHS Foundation Trust